Lanctot K

References (3)

Title : Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation - Mohammad_2017_Expert.Opin.Drug.Saf_16_1009
Author(s) : Mohammad D , Chan P , Bradley J , Lanctot K , Herrmann N
Ref : Expert Opin Drug Safety , 16 :1009 , 2017
Abstract : Mohammad_2017_Expert.Opin.Drug.Saf_16_1009
ESTHER : Mohammad_2017_Expert.Opin.Drug.Saf_16_1009
PubMedSearch : Mohammad_2017_Expert.Opin.Drug.Saf_16_1009
PubMedID: 28678552

Title : Memantine in dementia: a review of the current evidence - Herrmann_2011_Expert.Opin.Pharmacother_12_787
Author(s) : Herrmann N , Li A , Lanctot K
Ref : Expert Opin Pharmacother , 12 :787 , 2011
Abstract : Herrmann_2011_Expert.Opin.Pharmacother_12_787
ESTHER : Herrmann_2011_Expert.Opin.Pharmacother_12_787
PubMedSearch : Herrmann_2011_Expert.Opin.Pharmacother_12_787
PubMedID: 21385152

Title : Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia - Hogan_2008_CMAJ_179_1019
Author(s) : Hogan DB , Bailey P , Black S , Carswell A , Chertkow H , Clarke B , Cohen C , Fisk JD , Forbes D , Man-Son-Hing M , Lanctot K , Morgan D , Thorpe L
Ref : Cmaj , 179 :1019 , 2008
Abstract : Hogan_2008_CMAJ_179_1019
ESTHER : Hogan_2008_CMAJ_179_1019
PubMedSearch : Hogan_2008_CMAJ_179_1019
PubMedID: 18981443